

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 9.16381898 |
| 2 | viral transcription (GO:0019083) | 6.90049183 |
| 3 | hemidesmosome assembly (GO:0031581) | 6.53435750 |
| 4 | translational termination (GO:0006415) | 6.47229335 |
| 5 | ribosomal small subunit biogenesis (GO:0042274) | 6.19940197 |
| 6 | maturation of SSU-rRNA (GO:0030490) | 5.91582958 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.30593947 |
| 8 | translational elongation (GO:0006414) | 5.21880893 |
| 9 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.21225741 |
| 10 | regulation of phospholipase A2 activity (GO:0032429) | 5.14795223 |
| 11 | protein targeting to ER (GO:0045047) | 5.13180365 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.11239251 |
| 13 | cotranslational protein targeting to membrane (GO:0006613) | 5.08944957 |
| 14 | viral life cycle (GO:0019058) | 5.07709749 |
| 15 | detection of bacterium (GO:0016045) | 5.01794363 |
| 16 | regulation of water loss via skin (GO:0033561) | 5.00043803 |
| 17 | cellular protein complex disassembly (GO:0043624) | 4.95367870 |
| 18 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.94518677 |
| 19 | response to peptidoglycan (GO:0032494) | 4.92488039 |
| 20 | ribosomal large subunit biogenesis (GO:0042273) | 4.90196338 |
| 21 | ribosomal small subunit assembly (GO:0000028) | 4.88667359 |
| 22 | protein localization to endoplasmic reticulum (GO:0070972) | 4.83841750 |
| 23 | intestinal cholesterol absorption (GO:0030299) | 4.83549070 |
| 24 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.72242348 |
| 25 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.68951233 |
| 26 | phospholipid efflux (GO:0033700) | 4.67812290 |
| 27 | establishment of skin barrier (GO:0061436) | 4.65236029 |
| 28 | response to muramyl dipeptide (GO:0032495) | 4.64898581 |
| 29 | positive regulation by symbiont of host defense response (GO:0052509) | 4.58450589 |
| 30 | modulation by symbiont of host defense response (GO:0052031) | 4.58450589 |
| 31 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.58450589 |
| 32 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.58450589 |
| 33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.58450589 |
| 34 | modulation by symbiont of host immune response (GO:0052553) | 4.58450589 |
| 35 | detection of other organism (GO:0098543) | 4.51978025 |
| 36 | negative regulation of cell killing (GO:0031342) | 4.49418495 |
| 37 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.49418495 |
| 38 | intestinal absorption (GO:0050892) | 4.47155439 |
| 39 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.41597330 |
| 40 | fatty acid elongation (GO:0030497) | 4.28545358 |
| 41 | regulation of chemokine secretion (GO:0090196) | 4.22108262 |
| 42 | atrioventricular valve morphogenesis (GO:0003181) | 4.20080710 |
| 43 | protein complex disassembly (GO:0043241) | 4.18813986 |
| 44 | cellular extravasation (GO:0045123) | 4.15801446 |
| 45 | leukocyte aggregation (GO:0070486) | 4.15478004 |
| 46 | keratinocyte proliferation (GO:0043616) | 4.12889561 |
| 47 | translational initiation (GO:0006413) | 4.10322481 |
| 48 | angiotensin maturation (GO:0002003) | 4.07994414 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 3.96254923 |
| 50 | regulation of gamma-delta T cell activation (GO:0046643) | 3.95815301 |
| 51 | sphingoid metabolic process (GO:0046519) | 3.94856850 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.90183150 |
| 53 | negative thymic T cell selection (GO:0045060) | 3.88547594 |
| 54 | interferon-gamma secretion (GO:0072643) | 3.88058316 |
| 55 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.84946989 |
| 56 | positive thymic T cell selection (GO:0045059) | 3.82854778 |
| 57 | regulation of natural killer cell differentiation (GO:0032823) | 3.82758518 |
| 58 | macromolecular complex disassembly (GO:0032984) | 3.81390192 |
| 59 | regulation of cholesterol esterification (GO:0010872) | 3.81118385 |
| 60 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.78717453 |
| 61 | adhesion of symbiont to host cell (GO:0044650) | 3.77581628 |
| 62 | virion attachment to host cell (GO:0019062) | 3.77581628 |
| 63 | detection of external biotic stimulus (GO:0098581) | 3.72933941 |
| 64 | thymic T cell selection (GO:0045061) | 3.69312530 |
| 65 | macrophage activation involved in immune response (GO:0002281) | 3.66949907 |
| 66 | keratinization (GO:0031424) | 3.66798307 |
| 67 | negative T cell selection (GO:0043383) | 3.64681061 |
| 68 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.64273687 |
| 69 | keratinocyte differentiation (GO:0030216) | 3.63082821 |
| 70 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.60420439 |
| 71 | very long-chain fatty acid metabolic process (GO:0000038) | 3.59649933 |
| 72 | negative regulation of T cell mediated immunity (GO:0002710) | 3.58056189 |
| 73 | neutrophil activation involved in immune response (GO:0002283) | 3.57123631 |
| 74 | protein targeting to membrane (GO:0006612) | 3.55796203 |
| 75 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.53391933 |
| 76 | carnitine metabolic process (GO:0009437) | 3.50957717 |
| 77 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.50652955 |
| 78 | negative regulation of sterol transport (GO:0032372) | 3.48923895 |
| 79 | negative regulation of cholesterol transport (GO:0032375) | 3.48923895 |
| 80 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.48323495 |
| 81 | negative regulation of lipase activity (GO:0060192) | 3.45542128 |
| 82 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.44482776 |
| 83 | multicellular organismal water homeostasis (GO:0050891) | 3.40763927 |
| 84 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.39912109 |
| 85 | T cell selection (GO:0045058) | 3.39885811 |
| 86 | sphingosine metabolic process (GO:0006670) | 3.39262083 |
| 87 | negative regulation of interleukin-12 production (GO:0032695) | 3.38610186 |
| 88 | response to host immune response (GO:0052572) | 3.38356546 |
| 89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.38356546 |
| 90 | regulation of hypersensitivity (GO:0002883) | 3.37784702 |
| 91 | detection of biotic stimulus (GO:0009595) | 3.36803925 |
| 92 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.36347352 |
| 93 | response to host (GO:0075136) | 3.36347352 |
| 94 | response to host defenses (GO:0052200) | 3.36347352 |
| 95 | high-density lipoprotein particle remodeling (GO:0034375) | 3.34673153 |
| 96 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.34463795 |
| 97 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.32333031 |
| 98 | amino-acid betaine metabolic process (GO:0006577) | 3.30844512 |
| 99 | regulation of cholesterol homeostasis (GO:2000188) | 3.28331074 |
| 100 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.27839288 |
| 101 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.26788796 |
| 102 | primary alcohol catabolic process (GO:0034310) | 3.25780215 |
| 103 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.21522075 |
| 104 | epidermis development (GO:0008544) | 3.21483920 |
| 105 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.21223715 |
| 106 | germinal center formation (GO:0002467) | 3.21113293 |
| 107 | positive regulation of B cell differentiation (GO:0045579) | 3.20339356 |
| 108 | adhesion of symbiont to host (GO:0044406) | 3.18905252 |
| 109 | mannose metabolic process (GO:0006013) | 3.17876553 |
| 110 | detection of molecule of bacterial origin (GO:0032490) | 3.15499416 |
| 111 | plasma lipoprotein particle assembly (GO:0034377) | 3.14981764 |
| 112 | B cell receptor signaling pathway (GO:0050853) | 3.13748144 |
| 113 | regulation of ruffle assembly (GO:1900027) | 3.12672697 |
| 114 | response to phenylpropanoid (GO:0080184) | 3.12270174 |
| 115 | urea cycle (GO:0000050) | 3.11895548 |
| 116 | urea metabolic process (GO:0019627) | 3.11895548 |
| 117 | regulation of leukocyte degranulation (GO:0043300) | 3.10382144 |
| 118 | positive regulation of p38MAPK cascade (GO:1900745) | 3.10077845 |
| 119 | diol metabolic process (GO:0034311) | 3.09274265 |
| 120 | negative regulation of interferon-gamma production (GO:0032689) | 3.09172701 |
| 121 | keratinocyte development (GO:0003334) | 3.06639803 |
| 122 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.06607080 |
| 123 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.06524511 |
| 124 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.05941040 |
| 125 | regulation of mast cell degranulation (GO:0043304) | 3.05077283 |
| 126 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.04219618 |
| 127 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.04219618 |
| 128 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.04218041 |
| 129 | positive T cell selection (GO:0043368) | 3.03668539 |
| 130 | epidermal cell differentiation (GO:0009913) | 3.03049787 |
| 131 | negative regulation of stress fiber assembly (GO:0051497) | 3.01596780 |
| 132 | skin morphogenesis (GO:0043589) | 3.00540012 |
| 133 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.99664277 |
| 134 | water homeostasis (GO:0030104) | 2.98657450 |
| 135 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95900187 |
| 136 | positive regulation of chemokine secretion (GO:0090197) | 2.93873737 |
| 137 | molting cycle (GO:0042303) | 2.92235557 |
| 138 | hair cycle (GO:0042633) | 2.92235557 |
| 139 | lipoprotein metabolic process (GO:0042157) | 2.91678765 |
| 140 | cholesterol efflux (GO:0033344) | 2.90396580 |
| 141 | respiratory burst (GO:0045730) | 2.87410043 |
| 142 | flavonoid metabolic process (GO:0009812) | 2.87374133 |
| 143 | cholesterol homeostasis (GO:0042632) | 2.86415683 |
| 144 | myeloid cell activation involved in immune response (GO:0002275) | 2.85349567 |
| 145 | gland morphogenesis (GO:0022612) | 2.85220180 |
| 146 | protein-lipid complex remodeling (GO:0034368) | 2.85125991 |
| 147 | macromolecular complex remodeling (GO:0034367) | 2.85125991 |
| 148 | plasma lipoprotein particle remodeling (GO:0034369) | 2.85125991 |
| 149 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.84553721 |
| 150 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.84285558 |
| 151 | protein carboxylation (GO:0018214) | 2.84285558 |
| 152 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.84261974 |
| 153 | regulation of interleukin-8 secretion (GO:2000482) | 2.83520798 |
| 154 | negative regulation of interleukin-8 production (GO:0032717) | 2.82693173 |
| 155 | protein-lipid complex assembly (GO:0065005) | 2.82607517 |
| 156 | tolerance induction (GO:0002507) | 2.81971408 |
| 157 | regulation of B cell differentiation (GO:0045577) | 2.81507181 |
| 158 | fibrinolysis (GO:0042730) | 2.81291238 |
| 159 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.80131149 |
| 160 | reverse cholesterol transport (GO:0043691) | 2.79724160 |
| 161 | response to laminar fluid shear stress (GO:0034616) | 2.76138590 |
| 162 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.72975946 |
| 163 | response to interleukin-15 (GO:0070672) | 2.71697925 |
| 164 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.71404567 |
| 165 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.71279424 |
| 166 | neutrophil activation (GO:0042119) | 2.71162333 |
| 167 | neutrophil mediated immunity (GO:0002446) | 2.69245427 |
| 168 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.67834849 |
| 169 | histone H3-K36 demethylation (GO:0070544) | 2.67783202 |
| 170 | negative regulation of interleukin-6 production (GO:0032715) | 2.67664259 |
| 171 | positive regulation of granulocyte differentiation (GO:0030854) | 2.65427842 |
| 172 | immunoglobulin mediated immune response (GO:0016064) | 2.62105871 |
| 173 | embryonic process involved in female pregnancy (GO:0060136) | 2.61817510 |
| 174 | granulocyte activation (GO:0036230) | 2.58595023 |
| 175 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.58154866 |
| 176 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.57291880 |
| 177 | regulation of necroptotic process (GO:0060544) | 2.57076346 |
| 178 | T cell migration (GO:0072678) | 2.56298806 |
| 179 | Peyers patch development (GO:0048541) | 2.55839726 |
| 180 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.55839726 |
| 181 | macrophage activation (GO:0042116) | 2.54390065 |
| 182 | defense response to protozoan (GO:0042832) | 2.54328916 |
| 183 | pinocytosis (GO:0006907) | 2.52889505 |
| 184 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.52045417 |
| 185 | negative regulation of innate immune response (GO:0045824) | 2.51812693 |
| 186 | regulation of histone H3-K27 methylation (GO:0061085) | 2.51346119 |
| 187 | histone H3-K4 trimethylation (GO:0080182) | 2.48417181 |
| 188 | response to protozoan (GO:0001562) | 2.46476184 |
| 189 | regulation of regulated secretory pathway (GO:1903305) | 2.46464991 |
| 190 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.46298224 |
| 191 | megakaryocyte development (GO:0035855) | 2.45776872 |
| 192 | NIK/NF-kappaB signaling (GO:0038061) | 2.43833576 |
| 193 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.43611773 |
| 194 | microglial cell activation (GO:0001774) | 2.43349779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.62285841 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.01408469 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.56725224 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.54018887 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.95034797 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.85856950 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.84966735 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.66217082 |
| 9 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.59848876 |
| 10 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.57348967 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.53005763 |
| 12 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.51778024 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.48511240 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.47235849 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.43627143 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.39726203 |
| 17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.38920318 |
| 18 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.31652138 |
| 19 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.25649007 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.19346765 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.16244069 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.12150112 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.10221621 |
| 24 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09668480 |
| 25 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.06943459 |
| 26 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.06719382 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.00298505 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 14.5492306 |
| 29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.99837206 |
| 30 | * MAF_26560356_Chip-Seq_TH2_Human | 1.96733739 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.96255741 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.95961755 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93138830 |
| 34 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.88794611 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81008058 |
| 36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.79343088 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78040345 |
| 38 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.77509364 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.77190002 |
| 40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.75305410 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.73943158 |
| 42 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.71295307 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.69866625 |
| 44 | MYB_26560356_Chip-Seq_TH2_Human | 1.67499632 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.64178572 |
| 46 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.62103494 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.60330364 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.59859336 |
| 49 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.56920024 |
| 50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.55597918 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55590186 |
| 52 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.53892035 |
| 53 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.53892035 |
| 54 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49789448 |
| 55 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.49371100 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.49275439 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.45249222 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41842980 |
| 59 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.40835710 |
| 60 | P68_20966046_ChIP-Seq_HELA_Human | 1.40389680 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.39662975 |
| 62 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39096317 |
| 63 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37256750 |
| 64 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.35585940 |
| 65 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.35457168 |
| 66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34389093 |
| 67 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.34053237 |
| 68 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33689108 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32799555 |
| 70 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.32234188 |
| 71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.31936768 |
| 72 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31933129 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31226459 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30543995 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29482275 |
| 76 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.29139536 |
| 77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.28618625 |
| 78 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25433131 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24561799 |
| 80 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.23865325 |
| 81 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.23366276 |
| 82 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.22962041 |
| 83 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.22506592 |
| 84 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20784615 |
| 85 | KDM2B_26808549_Chip-Seq_K562_Human | 1.20754815 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20353757 |
| 87 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.19924887 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19471450 |
| 89 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18058074 |
| 90 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17991687 |
| 91 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.17965265 |
| 92 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17808120 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17507205 |
| 94 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16937487 |
| 95 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16524088 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15925107 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13800956 |
| 98 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.13472542 |
| 99 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.13067616 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12822319 |
| 101 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12501351 |
| 102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12037310 |
| 103 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.11005604 |
| 104 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10797732 |
| 105 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09990216 |
| 106 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09633912 |
| 107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08786178 |
| 108 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08338338 |
| 109 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.08146171 |
| 110 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08019998 |
| 111 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.07647561 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06679554 |
| 113 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06043567 |
| 114 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.06006367 |
| 115 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02236657 |
| 116 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.02036560 |
| 117 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01333233 |
| 118 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00892574 |
| 119 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99478166 |
| 120 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99257379 |
| 121 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.99199480 |
| 122 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97791619 |
| 123 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96403899 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96258778 |
| 125 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95956123 |
| 126 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94497360 |
| 127 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94367440 |
| 128 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.94346248 |
| 129 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94142330 |
| 130 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.93855086 |
| 131 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93207426 |
| 132 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.90681630 |
| 133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89108957 |
| 134 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.89000348 |
| 135 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.88223140 |
| 136 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.88223140 |
| 137 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.88223140 |
| 138 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.87682874 |
| 139 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86872629 |
| 140 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85735928 |
| 141 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85388709 |
| 142 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.84837543 |
| 143 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.84304012 |
| 144 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.82646691 |
| 145 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.81741524 |
| 146 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.79407330 |
| 147 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.75634949 |
| 148 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.75544926 |
| 149 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.75098857 |
| 150 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.74398630 |
| 151 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.73424144 |
| 152 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.72967902 |
| 153 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.71818232 |
| 154 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.71669073 |
| 155 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.71075033 |
| 156 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70553693 |
| 157 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.68604083 |
| 158 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.68196240 |
| 159 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.68143914 |
| 160 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.66556182 |
| 161 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.66273170 |
| 162 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.66157553 |
| 163 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.65689054 |
| 164 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.65477726 |
| 165 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.65396202 |
| 166 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.64784452 |
| 167 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.64767597 |
| 168 | GATA1_19941826_ChIP-Seq_K562_Human | 0.63168687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002796_impaired_skin_barrier | 5.74612982 |
| 2 | MP0002254_reproductive_system_inflammat | 5.21840039 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 4.59879632 |
| 4 | MP0005360_urolithiasis | 4.58675370 |
| 5 | MP0005501_abnormal_skin_physiology | 3.32325049 |
| 6 | MP0003941_abnormal_skin_development | 3.22414070 |
| 7 | MP0001346_abnormal_lacrimal_gland | 3.07228422 |
| 8 | MP0000467_abnormal_esophagus_morphology | 2.98742464 |
| 9 | MP0000579_abnormal_nail_morphology | 2.93488897 |
| 10 | MP0002060_abnormal_skin_morphology | 2.88700810 |
| 11 | MP0002098_abnormal_vibrissa_morphology | 2.88339216 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.79208391 |
| 13 | MP0001216_abnormal_epidermal_layer | 2.69578372 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.61205769 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.60124468 |
| 16 | MP0005275_abnormal_skin_tensile | 2.57703888 |
| 17 | MP0010678_abnormal_skin_adnexa | 2.57555888 |
| 18 | MP0000685_abnormal_immune_system | 2.55056834 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.51741479 |
| 20 | MP0009379_abnormal_foot_pigmentation | 2.50755669 |
| 21 | MP0009278_abnormal_bone_marrow | 2.49936336 |
| 22 | MP0000383_abnormal_hair_follicle | 2.47257835 |
| 23 | MP0003303_peritoneal_inflammation | 2.45964292 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 2.36426117 |
| 25 | MP0002396_abnormal_hematopoietic_system | 2.33358300 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 2.32482559 |
| 27 | MP0004381_abnormal_hair_follicle | 2.22343987 |
| 28 | MP0001800_abnormal_humoral_immune | 2.21516216 |
| 29 | * MP0002419_abnormal_innate_immunity | 2.19516178 |
| 30 | MP0003453_abnormal_keratinocyte_physiol | 2.18895748 |
| 31 | MP0010771_integument_phenotype | 2.16210356 |
| 32 | MP0008260_abnormal_autophagy | 2.10975276 |
| 33 | * MP0005000_abnormal_immune_tolerance | 2.07083389 |
| 34 | MP0009840_abnormal_foam_cell | 2.06562500 |
| 35 | MP0003172_abnormal_lysosome_physiology | 2.02862173 |
| 36 | MP0003566_abnormal_cell_adhesion | 2.00458395 |
| 37 | * MP0002420_abnormal_adaptive_immunity | 1.99124960 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.98140824 |
| 39 | MP0004947_skin_inflammation | 1.98089470 |
| 40 | * MP0001819_abnormal_immune_cell | 1.97285462 |
| 41 | MP0008875_abnormal_xenobiotic_pharmacok | 1.95792075 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.93817550 |
| 43 | MP0000377_abnormal_hair_follicle | 1.93244447 |
| 44 | MP0002723_abnormal_immune_serum | 1.92503515 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.91528474 |
| 46 | MP0000647_abnormal_sebaceous_gland | 1.88270206 |
| 47 | MP0005387_immune_system_phenotype | 1.85527955 |
| 48 | MP0001790_abnormal_immune_system | 1.85527955 |
| 49 | MP0005671_abnormal_response_to | 1.84694186 |
| 50 | MP0002398_abnormal_bone_marrow | 1.82507609 |
| 51 | MP0005365_abnormal_bile_salt | 1.75925430 |
| 52 | MP0000427_abnormal_hair_cycle | 1.71787450 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 1.65778386 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.64716387 |
| 55 | MP0002405_respiratory_system_inflammati | 1.61850177 |
| 56 | MP0000716_abnormal_immune_system | 1.61632580 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.60619674 |
| 58 | MP0002722_abnormal_immune_system | 1.59476670 |
| 59 | MP0001191_abnormal_skin_condition | 1.58420348 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.55459927 |
| 61 | MP0005464_abnormal_platelet_physiology | 1.55152370 |
| 62 | MP0010329_abnormal_lipoprotein_level | 1.52614387 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.50097405 |
| 64 | MP0009931_abnormal_skin_appearance | 1.48323784 |
| 65 | MP0009785_altered_susceptibility_to | 1.47459835 |
| 66 | MP0000516_abnormal_urinary_system | 1.46302912 |
| 67 | MP0005367_renal/urinary_system_phenotyp | 1.46302912 |
| 68 | MP0005023_abnormal_wound_healing | 1.45887402 |
| 69 | MP0003828_pulmonary_edema | 1.44262048 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.44217998 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 1.39624263 |
| 72 | MP0002429_abnormal_blood_cell | 1.37614454 |
| 73 | MP0008057_abnormal_DNA_replication | 1.35066687 |
| 74 | MP0000762_abnormal_tongue_morphology | 1.32982697 |
| 75 | MP0001849_ear_inflammation | 1.29268396 |
| 76 | MP0003866_abnormal_defecation | 1.28958889 |
| 77 | MP0005409_darkened_coat_color | 1.27684552 |
| 78 | MP0009053_abnormal_anal_canal | 1.26871621 |
| 79 | MP0001873_stomach_inflammation | 1.26137192 |
| 80 | MP0001851_eye_inflammation | 1.23974305 |
| 81 | MP0003252_abnormal_bile_duct | 1.23047300 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.22702524 |
| 83 | MP0010030_abnormal_orbit_morphology | 1.17594025 |
| 84 | MP0006082_CNS_inflammation | 1.15060461 |
| 85 | MP0005310_abnormal_salivary_gland | 1.13447485 |
| 86 | MP0004264_abnormal_extraembryonic_tissu | 1.11625081 |
| 87 | MP0001348_abnormal_lacrimal_gland | 1.09815363 |
| 88 | MP0004510_myositis | 1.08278213 |
| 89 | MP0009384_cardiac_valve_regurgitation | 1.07613640 |
| 90 | MP0001243_abnormal_dermal_layer | 1.06234847 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 1.06110382 |
| 92 | MP0002998_abnormal_bone_remodeling | 1.02537409 |
| 93 | MP0000015_abnormal_ear_pigmentation | 1.00672149 |
| 94 | MP0001340_abnormal_eyelid_morphology | 0.99562038 |
| 95 | MP0002019_abnormal_tumor_incidence | 0.98148627 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.97209505 |
| 97 | MP0000367_abnormal_coat/_hair | 0.96865041 |
| 98 | MP0000490_abnormal_crypts_of | 0.95330178 |
| 99 | MP0008469_abnormal_protein_level | 0.95181364 |
| 100 | MP0000538_abnormal_urinary_bladder | 0.93036343 |
| 101 | MP0002132_abnormal_respiratory_system | 0.92672199 |
| 102 | * MP0003436_decreased_susceptibility_to | 0.90872166 |
| 103 | MP0003191_abnormal_cellular_cholesterol | 0.90628282 |
| 104 | MP0002249_abnormal_larynx_morphology | 0.90289434 |
| 105 | MP0005076_abnormal_cell_differentiation | 0.90101785 |
| 106 | MP0004185_abnormal_adipocyte_glucose | 0.88406287 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.86921358 |
| 108 | MP0005621_abnormal_cell_physiology | 0.84968988 |
| 109 | MP0003385_abnormal_body_wall | 0.84475588 |
| 110 | MP0003183_abnormal_peptide_metabolism | 0.80493628 |
| 111 | MP0000627_abnormal_mammary_gland | 0.78114359 |
| 112 | MP0005451_abnormal_body_composition | 0.75828752 |
| 113 | MP0000566_synostosis | 0.75006394 |
| 114 | MP0003448_altered_tumor_morphology | 0.74940046 |
| 115 | MP0003724_increased_susceptibility_to | 0.74903036 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.74196349 |
| 117 | MP0003091_abnormal_cell_migration | 0.72711388 |
| 118 | MP0004272_abnormal_basement_membrane | 0.71962709 |
| 119 | MP0003011_delayed_dark_adaptation | 0.70822373 |
| 120 | MP0000609_abnormal_liver_physiology | 0.70284308 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.69673729 |
| 122 | MP0003111_abnormal_nucleus_morphology | 0.68719567 |
| 123 | MP0002933_joint_inflammation | 0.68459975 |
| 124 | MP0005397_hematopoietic_system_phenotyp | 0.67721336 |
| 125 | MP0001545_abnormal_hematopoietic_system | 0.67721336 |
| 126 | MP0005375_adipose_tissue_phenotype | 0.65350203 |
| 127 | MP0002111_abnormal_tail_morphology | 0.65224336 |
| 128 | MP0002148_abnormal_hypersensitivity_rea | 0.63589029 |
| 129 | MP0009763_increased_sensitivity_to | 0.63425420 |
| 130 | MP0002118_abnormal_lipid_homeostasis | 0.63415613 |
| 131 | MP0010155_abnormal_intestine_physiology | 0.62456279 |
| 132 | MP0000613_abnormal_salivary_gland | 0.60666023 |
| 133 | MP0005623_abnormal_meninges_morphology | 0.60595336 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.58784402 |
| 135 | MP0003136_yellow_coat_color | 0.58638038 |
| 136 | MP0000477_abnormal_intestine_morphology | 0.57674724 |
| 137 | MP0008007_abnormal_cellular_replicative | 0.55628993 |
| 138 | MP0002282_abnormal_trachea_morphology | 0.55321398 |
| 139 | MP0009764_decreased_sensitivity_to | 0.54435454 |
| 140 | MP0006054_spinal_hemorrhage | 0.51557687 |
| 141 | MP0003300_gastrointestinal_ulcer | 0.51145230 |
| 142 | MP0005319_abnormal_enzyme/_coenzyme | 0.49939539 |
| 143 | MP0000858_altered_metastatic_potential | 0.49529372 |
| 144 | MP0002006_tumorigenesis | 0.49239334 |
| 145 | MP0005332_abnormal_amino_acid | 0.49023296 |
| 146 | MP0009643_abnormal_urine_homeostasis | 0.48742849 |
| 147 | MP0000470_abnormal_stomach_morphology | 0.45662426 |
| 148 | MP0005083_abnormal_biliary_tract | 0.45218774 |
| 149 | MP0002009_preneoplasia | 0.44326913 |
| 150 | MP0001853_heart_inflammation | 0.43542166 |
| 151 | MP0002166_altered_tumor_susceptibility | 0.42565439 |
| 152 | MP0005025_abnormal_response_to | 0.42506005 |
| 153 | MP0000537_abnormal_urethra_morphology | 0.42265927 |
| 154 | MP0003075_altered_response_to | 0.41972163 |
| 155 | MP0002090_abnormal_vision | 0.41038532 |
| 156 | * MP0001533_abnormal_skeleton_physiology | 0.40385839 |
| 157 | MP0004858_abnormal_nervous_system | 0.40243835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.74483147 |
| 2 | Fragile nails (HP:0001808) | 5.25190793 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.09008641 |
| 4 | Woolly hair (HP:0002224) | 5.00466894 |
| 5 | Parakeratosis (HP:0001036) | 4.87884875 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 4.79762346 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.76307012 |
| 8 | Hypotrichosis (HP:0001006) | 4.74905825 |
| 9 | Plantar hyperkeratosis (HP:0007556) | 4.61302333 |
| 10 | Increased IgE level (HP:0003212) | 4.29198736 |
| 11 | Abnormal hemoglobin (HP:0011902) | 4.21687542 |
| 12 | Reticulocytopenia (HP:0001896) | 4.15643497 |
| 13 | Recurrent abscess formation (HP:0002722) | 4.07991039 |
| 14 | Onycholysis (HP:0001806) | 4.02599632 |
| 15 | Abnormal number of erythroid precursors (HP:0012131) | 3.87431349 |
| 16 | Milia (HP:0001056) | 3.82465376 |
| 17 | Macrocytic anemia (HP:0001972) | 3.81863536 |
| 18 | Myositis (HP:0100614) | 3.78141161 |
| 19 | Xanthomatosis (HP:0000991) | 3.75772398 |
| 20 | Hypobetalipoproteinemia (HP:0003563) | 3.67133052 |
| 21 | Erythema (HP:0010783) | 3.65491216 |
| 22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.58180672 |
| 23 | Pili torti (HP:0003777) | 3.57595945 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.57337929 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.53709462 |
| 26 | Abnormality of the axillary hair (HP:0100134) | 3.46800625 |
| 27 | Abnormality of secondary sexual hair (HP:0009888) | 3.46800625 |
| 28 | Recurrent skin infections (HP:0001581) | 3.45010513 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.32324720 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.32181749 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.32068447 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 3.32068447 |
| 33 | Abnormal blistering of the skin (HP:0008066) | 3.30291958 |
| 34 | Abnormality of the 2nd finger (HP:0004100) | 3.23494660 |
| 35 | Palmoplantar hyperkeratosis (HP:0000972) | 3.23378005 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 3.21633971 |
| 37 | Orchitis (HP:0100796) | 3.17151182 |
| 38 | Intrahepatic cholestasis (HP:0001406) | 3.13459776 |
| 39 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.11885286 |
| 40 | Pallor (HP:0000980) | 3.10619757 |
| 41 | Nail dystrophy (HP:0008404) | 3.09225016 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.05687063 |
| 43 | Sparse eyelashes (HP:0000653) | 3.04115195 |
| 44 | Palmar hyperkeratosis (HP:0010765) | 3.02148597 |
| 45 | Meningitis (HP:0001287) | 3.00603682 |
| 46 | Acanthocytosis (HP:0001927) | 2.96473271 |
| 47 | Severe Myopia (HP:0011003) | 2.93666983 |
| 48 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.93196723 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.92215150 |
| 50 | Optic neuritis (HP:0100653) | 2.92215150 |
| 51 | Recurrent viral infections (HP:0004429) | 2.88366589 |
| 52 | Gastrointestinal infarctions (HP:0005244) | 2.88351231 |
| 53 | Colitis (HP:0002583) | 2.82978410 |
| 54 | Erythroderma (HP:0001019) | 2.79704655 |
| 55 | Panhypogammaglobulinemia (HP:0003139) | 2.78240374 |
| 56 | Gastrointestinal inflammation (HP:0004386) | 2.77898440 |
| 57 | Cellulitis (HP:0100658) | 2.75982228 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.75676611 |
| 59 | Abnormality of the fingertips (HP:0001211) | 2.74400826 |
| 60 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70865307 |
| 61 | Obstructive lung disease (HP:0006536) | 2.70865307 |
| 62 | Gingivitis (HP:0000230) | 2.70239742 |
| 63 | Stenosis of the external auditory canal (HP:0000402) | 2.67939461 |
| 64 | Down-sloping shoulders (HP:0200021) | 2.65082370 |
| 65 | Malnutrition (HP:0004395) | 2.65058542 |
| 66 | Abnormality of nail color (HP:0100643) | 2.63033119 |
| 67 | Vascular calcification (HP:0004934) | 2.58619297 |
| 68 | Abnormal hair laboratory examination (HP:0003328) | 2.56670156 |
| 69 | Gangrene (HP:0100758) | 2.55941525 |
| 70 | Hypohidrosis (HP:0000966) | 2.55887357 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.54449173 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.54105038 |
| 73 | Sparse scalp hair (HP:0002209) | 2.53583538 |
| 74 | Atrophic scars (HP:0001075) | 2.50150849 |
| 75 | Prolonged bleeding time (HP:0003010) | 2.49496182 |
| 76 | Hydroxyprolinuria (HP:0003080) | 2.49271032 |
| 77 | Abnormality of proline metabolism (HP:0010907) | 2.49271032 |
| 78 | Trismus (HP:0000211) | 2.43803992 |
| 79 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.42837569 |
| 80 | Amyloidosis (HP:0011034) | 2.41795237 |
| 81 | Pruritus (HP:0000989) | 2.40988861 |
| 82 | Lip pit (HP:0100267) | 2.40662214 |
| 83 | Ileus (HP:0002595) | 2.39460490 |
| 84 | Abnormality of reticulocytes (HP:0004312) | 2.38854414 |
| 85 | Skin ulcer (HP:0200042) | 2.37127059 |
| 86 | Hypolipoproteinemia (HP:0010981) | 2.36527591 |
| 87 | Viral hepatitis (HP:0006562) | 2.35871960 |
| 88 | Abnormality of the gastric mucosa (HP:0004295) | 2.33176325 |
| 89 | Mesangial abnormality (HP:0001966) | 2.32155296 |
| 90 | Distal lower limb muscle weakness (HP:0009053) | 2.32144829 |
| 91 | Acanthosis nigricans (HP:0000956) | 2.32005484 |
| 92 | Cardiovascular calcification (HP:0011915) | 2.30823824 |
| 93 | Encephalitis (HP:0002383) | 2.30268854 |
| 94 | Broad face (HP:0000283) | 2.29405406 |
| 95 | Thick nail (HP:0001805) | 2.29122120 |
| 96 | Hypochromic anemia (HP:0001931) | 2.27898348 |
| 97 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.27769857 |
| 98 | Increased serum ferritin (HP:0003281) | 2.24098808 |
| 99 | Sepsis (HP:0100806) | 2.24080837 |
| 100 | Pterygium (HP:0001059) | 2.23304029 |
| 101 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.23096506 |
| 102 | Epistaxis (HP:0000421) | 2.20228666 |
| 103 | Cheilitis (HP:0100825) | 2.18951530 |
| 104 | Alopecia of scalp (HP:0002293) | 2.17443596 |
| 105 | Epidermoid cyst (HP:0200040) | 2.17421536 |
| 106 | Vasculitis (HP:0002633) | 2.16653067 |
| 107 | Granulocytopenia (HP:0001913) | 2.16575318 |
| 108 | Prolonged partial thromboplastin time (HP:0003645) | 2.15902389 |
| 109 | Popliteal pterygium (HP:0009756) | 2.15796549 |
| 110 | Corneal erosion (HP:0200020) | 2.12678928 |
| 111 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.11931421 |
| 112 | Spontaneous hematomas (HP:0007420) | 2.10725466 |
| 113 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.10052604 |
| 114 | Abnormality of lateral ventricle (HP:0030047) | 2.09595461 |
| 115 | Hypoplastic labia majora (HP:0000059) | 2.09221138 |
| 116 | Increased cerebral lipofuscin (HP:0011813) | 2.09109013 |
| 117 | Agammaglobulinemia (HP:0004432) | 2.06550681 |
| 118 | Hypercholesterolemia (HP:0003124) | 2.04854040 |
| 119 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.03227536 |
| 120 | Verrucae (HP:0200043) | 2.02439417 |
| 121 | Papilloma (HP:0012740) | 2.02439417 |
| 122 | Ridged nail (HP:0001807) | 2.01149679 |
| 123 | Fragile skin (HP:0001030) | 1.99844704 |
| 124 | Stomatitis (HP:0010280) | 1.99173588 |
| 125 | Conjugated hyperbilirubinemia (HP:0002908) | 1.98129767 |
| 126 | Deep venous thrombosis (HP:0002625) | 1.97038840 |
| 127 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.95946882 |
| 128 | Fat malabsorption (HP:0002630) | 1.95119624 |
| 129 | Hemoptysis (HP:0002105) | 1.93997175 |
| 130 | Arterial thrombosis (HP:0004420) | 1.93734714 |
| 131 | Ventricular tachycardia (HP:0004756) | 1.93177444 |
| 132 | Hypergammaglobulinemia (HP:0010702) | 1.92211692 |
| 133 | Chest pain (HP:0100749) | 1.91964553 |
| 134 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.91766110 |
| 135 | Concave nail (HP:0001598) | 1.91534214 |
| 136 | Hyporeflexia of lower limbs (HP:0002600) | 1.89394638 |
| 137 | Hypertriglyceridemia (HP:0002155) | 1.88110132 |
| 138 | Abnormality of T cell physiology (HP:0011840) | 1.87921390 |
| 139 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.87420504 |
| 140 | Urticaria (HP:0001025) | 1.87289980 |
| 141 | Abnormality of the labia majora (HP:0012881) | 1.86843282 |
| 142 | Subacute progressive viral hepatitis (HP:0006572) | 1.85735127 |
| 143 | Hyperlipoproteinemia (HP:0010980) | 1.85629246 |
| 144 | Dehydration (HP:0001944) | 1.84518700 |
| 145 | Hyperglycinuria (HP:0003108) | 1.83543394 |
| 146 | Osteomyelitis (HP:0002754) | 1.82530659 |
| 147 | Gingival bleeding (HP:0000225) | 1.82529883 |
| 148 | Pustule (HP:0200039) | 1.81353996 |
| 149 | Polygenic inheritance (HP:0010982) | 1.80472588 |
| 150 | Dysostosis multiplex (HP:0000943) | 1.80412284 |
| 151 | Curly hair (HP:0002212) | 1.79896609 |
| 152 | Fatigue (HP:0012378) | 1.79305867 |
| 153 | Slow saccadic eye movements (HP:0000514) | 1.79302591 |
| 154 | Poikilocytosis (HP:0004447) | 1.79032488 |
| 155 | Petechiae (HP:0000967) | 1.78709295 |
| 156 | Abnormality of iron homeostasis (HP:0011031) | 1.78330286 |
| 157 | Thin bony cortex (HP:0002753) | 1.78138293 |
| 158 | Bronchomalacia (HP:0002780) | 1.77759006 |
| 159 | Increased connective tissue (HP:0009025) | 1.77739668 |
| 160 | Abnormality of the peritoneum (HP:0002585) | 1.77326542 |
| 161 | Increased mean platelet volume (HP:0011877) | 1.77146715 |
| 162 | Abnormality of the columella (HP:0009929) | 1.76985221 |
| 163 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.76789119 |
| 164 | Abnormality of T cells (HP:0002843) | 1.76665283 |
| 165 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.76498562 |
| 166 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.76424697 |
| 167 | Sex reversal (HP:0012245) | 1.74684320 |
| 168 | Abnormal sex determination (HP:0012244) | 1.74684320 |
| 169 | Oral leukoplakia (HP:0002745) | 1.74551676 |
| 170 | Syringomyelia (HP:0003396) | 1.74239139 |
| 171 | Spinal cord lesions (HP:0100561) | 1.74239139 |
| 172 | Pulmonary infiltrates (HP:0002113) | 1.74131875 |
| 173 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73764005 |
| 174 | Loss of speech (HP:0002371) | 1.69324200 |
| 175 | Leukocytosis (HP:0001974) | 1.68968586 |
| 176 | T lymphocytopenia (HP:0005403) | 1.66872158 |
| 177 | Flat acetabular roof (HP:0003180) | 1.66671310 |
| 178 | Ectropion (HP:0000656) | 1.63772648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 7.53681445 |
| 2 | ERN1 | 3.95022684 |
| 3 | MAP3K3 | 3.89440480 |
| 4 | PRPF4B | 3.63283155 |
| 5 | MAPKAPK3 | 3.33314506 |
| 6 | TRIB3 | 3.13848219 |
| 7 | MAP2K3 | 3.13752145 |
| 8 | MET | 2.82251116 |
| 9 | CDK12 | 2.78482597 |
| 10 | LATS1 | 2.72512215 |
| 11 | PIM2 | 2.70150170 |
| 12 | RPS6KB2 | 2.60716534 |
| 13 | MAP3K2 | 2.58991878 |
| 14 | MST4 | 2.55572207 |
| 15 | LRRK2 | 2.35384027 |
| 16 | SMG1 | 2.33659690 |
| 17 | EEF2K | 2.11093912 |
| 18 | MAP3K13 | 2.08819916 |
| 19 | IRAK4 | 2.05589509 |
| 20 | EPHA2 | 1.89689027 |
| 21 | TRPM7 | 1.73881064 |
| 22 | JAK3 | 1.73689272 |
| 23 | RIPK1 | 1.66405716 |
| 24 | MAP3K10 | 1.58960411 |
| 25 | ZAP70 | 1.56857198 |
| 26 | MAP3K7 | 1.56791218 |
| 27 | CDK6 | 1.48193143 |
| 28 | MAPK11 | 1.45569064 |
| 29 | FER | 1.43746549 |
| 30 | FES | 1.41772386 |
| 31 | IRAK3 | 1.39435699 |
| 32 | MAP3K6 | 1.38112078 |
| 33 | TYK2 | 1.37309612 |
| 34 | CSK | 1.37176360 |
| 35 | TBK1 | 1.36747447 |
| 36 | STK10 | 1.32832083 |
| 37 | DYRK1B | 1.32197788 |
| 38 | TGFBR1 | 1.27504108 |
| 39 | PASK | 1.17494962 |
| 40 | EPHB2 | 1.17069892 |
| 41 | TNK2 | 1.16564738 |
| 42 | RIPK4 | 1.14468504 |
| 43 | BTK | 1.13424755 |
| 44 | STK24 | 1.13380616 |
| 45 | PKN2 | 1.07866472 |
| 46 | SYK | 1.04688044 |
| 47 | FGFR2 | 1.04674420 |
| 48 | TXK | 1.03562388 |
| 49 | CDK4 | 1.02868733 |
| 50 | FRK | 1.02502607 |
| 51 | JAK1 | 1.01397186 |
| 52 | SIK2 | 1.00119647 |
| 53 | FGFR4 | 0.98492529 |
| 54 | SIK1 | 0.98270963 |
| 55 | GRK6 | 0.97596623 |
| 56 | IRAK2 | 0.97203379 |
| 57 | CSF1R | 0.96119778 |
| 58 | CDK19 | 0.95433513 |
| 59 | PTK6 | 0.94972075 |
| 60 | PRKCI | 0.92207016 |
| 61 | MAPK12 | 0.91866759 |
| 62 | FGFR3 | 0.90530578 |
| 63 | TESK1 | 0.88051252 |
| 64 | IKBKB | 0.87717190 |
| 65 | RPS6KL1 | 0.85462001 |
| 66 | RPS6KC1 | 0.85462001 |
| 67 | TAOK2 | 0.83853147 |
| 68 | FGR | 0.83740452 |
| 69 | TESK2 | 0.82464699 |
| 70 | PRKD2 | 0.82366605 |
| 71 | MAPK7 | 0.81108265 |
| 72 | TLK1 | 0.80691472 |
| 73 | IRAK1 | 0.80569430 |
| 74 | LCK | 0.80225365 |
| 75 | BMX | 0.79986382 |
| 76 | NME2 | 0.79876563 |
| 77 | MTOR | 0.79050649 |
| 78 | MAP3K14 | 0.78721641 |
| 79 | KSR2 | 0.76796457 |
| 80 | ERBB4 | 0.76582517 |
| 81 | ERBB3 | 0.76075761 |
| 82 | BLK | 0.74514325 |
| 83 | BRD4 | 0.73237173 |
| 84 | CDC42BPA | 0.73040117 |
| 85 | MARK3 | 0.71728593 |
| 86 | SIK3 | 0.71699453 |
| 87 | MAP2K2 | 0.71468543 |
| 88 | ACVR1B | 0.69994099 |
| 89 | CAMK1D | 0.69775539 |
| 90 | RPS6KA6 | 0.69763089 |
| 91 | LYN | 0.69578499 |
| 92 | ERBB2 | 0.69558471 |
| 93 | IKBKE | 0.66605528 |
| 94 | PDPK1 | 0.66324423 |
| 95 | MAPK4 | 0.65567806 |
| 96 | PTK2 | 0.63089833 |
| 97 | MAP3K11 | 0.62873105 |
| 98 | TGFBR2 | 0.62619515 |
| 99 | PDK1 | 0.61516681 |
| 100 | MATK | 0.60411160 |
| 101 | SCYL2 | 0.59626782 |
| 102 | KDR | 0.58810188 |
| 103 | RET | 0.58319825 |
| 104 | MAPKAPK2 | 0.58116618 |
| 105 | NME1 | 0.54579693 |
| 106 | PIK3CG | 0.54353496 |
| 107 | RPS6KA2 | 0.54096798 |
| 108 | PRKG2 | 0.53851452 |
| 109 | HIPK2 | 0.53422327 |
| 110 | MAPK15 | 0.52215145 |
| 111 | CDK7 | 0.50878214 |
| 112 | TEC | 0.49650199 |
| 113 | JAK2 | 0.48574938 |
| 114 | ILK | 0.47038194 |
| 115 | MELK | 0.46605003 |
| 116 | MARK2 | 0.46139754 |
| 117 | NEK9 | 0.45797420 |
| 118 | TAOK1 | 0.44801724 |
| 119 | SGK3 | 0.44198899 |
| 120 | BMPR2 | 0.42896563 |
| 121 | MAP2K4 | 0.42112111 |
| 122 | ITK | 0.41514732 |
| 123 | TTN | 0.41482832 |
| 124 | GRK1 | 0.41392569 |
| 125 | MAPK3 | 0.39889543 |
| 126 | PAK2 | 0.38968790 |
| 127 | PIM1 | 0.38271668 |
| 128 | ABL2 | 0.38188415 |
| 129 | MAP3K8 | 0.36346429 |
| 130 | MUSK | 0.36218143 |
| 131 | STK11 | 0.36012875 |
| 132 | MAP3K1 | 0.35106087 |
| 133 | ABL1 | 0.34579788 |
| 134 | RPS6KA1 | 0.34026591 |
| 135 | MAP2K6 | 0.33876766 |
| 136 | DAPK3 | 0.33766733 |
| 137 | AURKB | 0.33140797 |
| 138 | ICK | 0.32058285 |
| 139 | AKT2 | 0.30254643 |
| 140 | EPHB1 | 0.29920034 |
| 141 | MAP2K1 | 0.29491631 |
| 142 | TAOK3 | 0.29166562 |
| 143 | MAP4K1 | 0.28955397 |
| 144 | KIT | 0.28323489 |
| 145 | HCK | 0.25587900 |
| 146 | BCKDK | 0.24794247 |
| 147 | CSNK1D | 0.24245511 |
| 148 | LATS2 | 0.23277248 |
| 149 | SRC | 0.23255613 |
| 150 | MAP3K9 | 0.22976533 |
| 151 | BCR | 0.22004429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.17241082 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.47786535 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.25546344 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.10429330 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.92132853 |
| 6 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.75646853 |
| 7 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.53765825 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.43482421 |
| 9 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.33374450 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.32515417 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30276701 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.28998041 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.23796556 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.18327802 |
| 15 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.15483307 |
| 16 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.10385791 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.09921344 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09176636 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 2.08611221 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.04760615 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92145624 |
| 22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.91151908 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.90087500 |
| 24 | Retinol metabolism_Homo sapiens_hsa00830 | 1.89005891 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.88383575 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87496877 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.81829588 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.76326687 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76011334 |
| 30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.73547440 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.73385140 |
| 32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.70983281 |
| 33 | Mineral absorption_Homo sapiens_hsa04978 | 1.65117923 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64945684 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.60283383 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59144333 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.58333420 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58270867 |
| 39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.57929628 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.56799120 |
| 41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.55584899 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.55233240 |
| 43 | Measles_Homo sapiens_hsa05162 | 1.52755342 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.50070435 |
| 45 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.48623819 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.47282688 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.45523825 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44881268 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.44646948 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44468523 |
| 51 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.43017829 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40724825 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38122665 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.36864420 |
| 55 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.36351917 |
| 56 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35633353 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 1.31326893 |
| 58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.24747997 |
| 59 | Malaria_Homo sapiens_hsa05144 | 1.23983664 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.23858042 |
| 61 | Galactose metabolism_Homo sapiens_hsa00052 | 1.18707580 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.18170294 |
| 63 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.17309703 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16889435 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 1.15261843 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.15248572 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.15172609 |
| 68 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.14599868 |
| 69 | Allograft rejection_Homo sapiens_hsa05330 | 1.14552362 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.13322793 |
| 71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.13268885 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.11401804 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 1.11008448 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.10014796 |
| 75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09843488 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 1.08512563 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07402405 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.07072978 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.06373206 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.05948529 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05900545 |
| 82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04389164 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 1.03897682 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.03804239 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.03262686 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02312762 |
| 87 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.02273513 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.01118913 |
| 89 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99994322 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.98363341 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.97506761 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.96799383 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.94881696 |
| 94 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.94846101 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.93144406 |
| 96 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91895850 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90275788 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.89192577 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89085302 |
| 100 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88311572 |
| 101 | Colorectal cancer_Homo sapiens_hsa05210 | 0.86520080 |
| 102 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86470037 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85834979 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85183433 |
| 105 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.85069472 |
| 106 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.84709884 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84080860 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.82719280 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82566322 |
| 110 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82248124 |
| 111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81290890 |
| 112 | Bladder cancer_Homo sapiens_hsa05219 | 0.80858116 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80242480 |
| 114 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77757424 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76940094 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76654721 |
| 117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76642539 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75905506 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75171347 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74163830 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73587927 |
| 122 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73458396 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.72351620 |
| 124 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72017318 |
| 125 | Prostate cancer_Homo sapiens_hsa05215 | 0.69212746 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69148066 |
| 127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.68204966 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.67955110 |
| 129 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67919815 |
| 130 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67871251 |
| 131 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.66754890 |
| 132 | Lysosome_Homo sapiens_hsa04142 | 0.66336366 |
| 133 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65447058 |
| 134 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64679337 |
| 135 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64515350 |
| 136 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62346364 |
| 137 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61746417 |
| 138 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60095565 |
| 139 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59535267 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | 0.59282630 |
| 141 | Endocytosis_Homo sapiens_hsa04144 | 0.59009766 |
| 142 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58498779 |
| 143 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58452150 |
| 144 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58405737 |
| 145 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58390753 |
| 146 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57560142 |
| 147 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56526815 |
| 148 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55420427 |
| 149 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54884324 |
| 150 | Lysine degradation_Homo sapiens_hsa00310 | 0.54440978 |
| 151 | Phagosome_Homo sapiens_hsa04145 | 0.51000850 |
| 152 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.50413574 |
| 153 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50226517 |
| 154 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.47840076 |
| 155 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46831593 |
| 156 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46277080 |
| 157 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41578364 |
| 158 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41383126 |
| 159 | Legionellosis_Homo sapiens_hsa05134 | 0.41159074 |
| 160 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.40953398 |
| 161 | Tight junction_Homo sapiens_hsa04530 | 0.35528096 |
| 162 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.35330729 |
| 163 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.34682626 |
| 164 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.33719210 |
| 165 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31513635 |
| 166 | Thyroid cancer_Homo sapiens_hsa05216 | 0.31435761 |
| 167 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31401635 |
| 168 | Hepatitis C_Homo sapiens_hsa05160 | 0.30430526 |
| 169 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29667739 |
| 170 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29298133 |
| 171 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25895871 |
| 172 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23574334 |
| 173 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.18673769 |
| 174 | Insulin resistance_Homo sapiens_hsa04931 | 0.18662950 |
| 175 | Pertussis_Homo sapiens_hsa05133 | 0.17550282 |
| 176 | Adherens junction_Homo sapiens_hsa04520 | 0.17493448 |
| 177 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.17449493 |
| 178 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.16711041 |
| 179 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.16633330 |
| 180 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16106883 |
| 181 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.15647290 |
| 182 | Salmonella infection_Homo sapiens_hsa05132 | 0.13641701 |

